Combination use of immune complexes and a Ca2 + channel blocker azelnidipine enhances interleukin-12 p40 secretion without T helper type 17 cytokine secretion in human monocyte-derived dendritic cells

Clinical and Experimental Immunology

Volumn 156, Issue 3, 2009, Pages 405-412

  Abe, T ^a   Fuse, I ^b   Narita, M ^c   Takahashi, M ^c   Aizawa, Y ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^c NIIGATA UNIVERSITY   (Japan)

Author keywords

Calcium; Cytokines interleukins; Dendritic cells (myeloid; FcRs; Monocyte derived); Plasmacytoid; Signalling signal transduction

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; AZELNIDIPINE; CALCIUM CHANNEL BLOCKING AGENT; FC RECEPTOR; IMMUNOGLOBULIN; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 23; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; CALCIUM TRANSPORT; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; ENDOCYTOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; HELPER CELL; HUMAN; HUMAN CELL; LIPID SOLUBILITY; LYMPHOCYTE DIFFERENTIATION; PHAGOCYTOSIS; PINOCYTOSIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANTIGEN-ANTIBODY COMPLEX; AZETIDINECARBOXYLIC ACID; CALCIUM CHANNEL BLOCKERS; CELLS, CULTURED; DENDRITIC CELLS; DIHYDROPYRIDINES; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66149084424     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2009.03911.x     Document Type: Article

References (51)

1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998 392 : 245 52. (Pubitemid 28155090)
2. Macatonia SE, Hosken NA, Litton M et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995 154 : 5071 9.
3. Trinchieri G, Scott P. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions. Res Immunol 1995 146 : 423 31. (Pubitemid 26054833)
4. Schuurhuis DH, Laban S, Toes RE et al. Immature dendritic cells acquire CD8(+) cytotoxic T lymphocyte priming capacity upon activation by T helper cell-independent or -dependent stimuli. J Exp Med 2000 192 : 145 50. (Pubitemid 30470816)
5. Sallusto F, Cella M, Danieli C, Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products. J Exp Med 1995 182 : 389 400.
6. Regnault A, Lankar D, Lacabanne V et al. Fcγ receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med 1999 189 : 371 80. (Pubitemid 29063258)
7. Schuurhuis DH, Ioan-Facsinay A, Nagelkerken B et al. Antigen-antibody immune complexes empower dendritic cells to efficiently prime specific CD8+ CTL responses in vivo. J Immunol 2002 168 : 2240 6. (Pubitemid 34171824)
8. Amigorena S, Bonnerot C. Fc receptors for IgG and antigen presentation on MHC class I and class II molecules. Semin Immunol 1999 11 : 385 90. (Pubitemid 30047500)
9. Amigorena S, Bonnerot C. Fc receptor signaling and trafficking: a connection for antigen processing. Immunol Rev 1999 172 : 279 84. (Pubitemid 30000485)
10. Serre K, Machy P, Grivel JC et al. Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells. J Immunol 1998 161 : 6059 67. (Pubitemid 28535976)
11. Akiyama K, Ebihara S, Yada A et al. Targeting apoptotic tumor cells to FcγR provides efficient and versatile vaccination against tumors by dendritic cells. J Immunol 2003 170 : 1641 8. (Pubitemid 36197377)
12. Kalergis AM, Ravetch JV. Inducing tumor immunity through the selective engagement of activating Fcγ receptors on dendritic cells. J Exp Med 2002 195 : 1653 9. (Pubitemid 34666079)
13. Rafiq K, Bergtold A, Clynes R. Immune complex-mediated antigen presentation induces tumor immunity. J Clin Invest 2002 110 : 71 9. (Pubitemid 34743467)
14. Schuurhuis DH, van Montfoort N, Ioan-Facsinay A et al. Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. J Immunol 2006 176 : 4573 80.
15. Swanson JA, Hoppe AD. The coordination of signaling during Fc receptor-mediated phagocytosis. J Leukoc Biol 2004 76 : 1093 103. (Pubitemid 39602944)
16. Vossebeld PJ, Homburg CH, Schweizer RC et al. Tyrosine phosphorylation-dependent activation of phosphatidylinositide 3-kinase occurs upstream of Ca2+-signalling induced by Fcγ receptor cross-linking in human neutrophils. Biochem J 1997 323 : 87 94. (Pubitemid 27153879)
17. Sánchez-Mejorada G, Rosales C. Fcγ receptor-mediated mitogen-activated protein kinase activation in monocytes is independent of Ras. J Biol Chem 1998 273 : 27610 19. (Pubitemid 28500484)
18. Ishizuka T, Chayama K, Takeda K et al. Mitogen-activated protein kinase activation through Fcε receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J Immunol 1999 162 : 2087 94. (Pubitemid 29288829)
19. Liu A, Takahashi M, Narita M et al. Generation of functional and mature dendritic cells from cord blood and bone marrow CD34+ cells by two-step culture combined with calcium ionophore treatment. J Immunol Method 2002 261 : 49 63. (Pubitemid 34175216)
20. Bachetoni A, D'Ambrosio A, Mariani P, Cortesini R, Quintieri F. Diltiazem impairs maturation and functions of human dendritic cells. Hum Immunol 2002 63 : 524 33. (Pubitemid 34686431)
21. Severa M, D'Ambrosio A, Giordani L, Quintieri F, Coccia E. Inhibition of interleukin-12 expression in diltiazem-treated dendritic cells through the reduction of nuclear factor-κB transcriptional activity. Biochem Pharmacol 2005 69 : 425 32. (Pubitemid 40103572)
22. Chen YL, Chen YS, Lin HH, Chan CW, Chen SC, Chen CH. Immunostimulatory flagellin from Burkholderia pseudomallei effects on an increase in the intracellular calcium concentration and up-regulation of TNF-α by mononuclear cells. Microbiol Immunol 2007 51 : 81 6.
23. Faries MB, Bedrosian I, Xu S et al. Calcium signaling inhibits interleukin-12 production and activates CD83(+) dendritic cells that induce Th2 cell development. Blood 2001 98 : 2489 97.
24. Goriely S, Goldman M. The interleukin-12 family: new players in transplantation immunity? Am J Transplant 2007 7 : 278 84. (Pubitemid 46096320)
25. Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood 2008 112 : 1557 69.
26. Langowski JL, Zhang X, Wu L et al. IL-23 promotes tumour incidence and growth. Nature 2006 442 : 461 5. (Pubitemid 44264796)
27. Yagil Y, Lustig A. Azelnidipine (CS-905), a novel dihydropyridine calcium channel blocker with gradual onset and prolonged duration of action. Cardiovasc Drug Rev 1995 13 : 137 48.
28. O'Sullivan B, Thomas R. CD40 and dendritic cell function. Crit Rev Immunol 2003 23 : 83 107. (Pubitemid 36875475)
29. Ismaili J, Rennesson J, Aksoy E et al. Monophosphoryl lipid A activates both human dendritic cells and T cells. J Immunol 2002 168 : 926 32. (Pubitemid 34049597)
30. Darville T, Milligan LB, Laffoon KK. Intravenous immunoglobulin inhibits staphylococcal toxin-induced human mononuclear phagocyte tumor necrosis factor alpha production. Infect Immun 1997 65 : 366 72. (Pubitemid 27053196)
31. 2+-dependent signal transduction pathways. J Immunol 1995 155 : 4685 91. (Pubitemid 3010803)
32. Saccani S, Pantano S, Natoli G. p38-dependent marking of inflammatory genes for increased NFκB recruitment. Nat Immunol 2002 3 : 69 75. (Pubitemid 34065620)
33. Goodridge HS, Harnett W, Liew FY, Harnett MM. Differential regulation of interleukin-12 p40 and p35 induction via Erk mitogen-activated protein kinase-dependent and -independent mechanisms and implications for bioactive IL-12 and IL-23 responses. Immunology 2003 109 : 415 25. (Pubitemid 36783268)
34. Beutler B, Hoebe K, Du X, Ulevitch RJ. How we detect microbes and respond to them: the Toll-like receptors and their transducers. J Leukoc Biol 2003 74 : 479 85. (Pubitemid 38040374)
35. O'neill LA. How toll-like receptors signal: what we know and what we don't know. Curr Opin Immunol 2006 18 : 3 9. (Pubitemid 43049641)
36. Corinti S, Albanesi C, la Sala A, Pastore S, Girolomani G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001 166 : 4312 18. (Pubitemid 32233711)
37. Nakahara T, Uchi H, Urabe K, Chen Q, Furue M, Moroi Y. Role of c-Jun N-terminal kinase on lipopolysaccharide induced maturation of human monocyte-derived dendritic cells. Int Immunol 2004 16 : 1701 9. (Pubitemid 40003858)
38. Yamane H, Kato T, Nariuchi H. Effective stimulation for IL-12 p35 mRNA accumulation and bioactive IL-12 production of antigen-presenting cells interacted with Th cells. J Immunol 1999 162 : 6433 41. (Pubitemid 29309364)
39. Chan SH, Perussia B, Gupta JW et al. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med 1991 173 : 869 79.
40. Mikols CL, Yan L, Norris JY et al. IL-12 p80 is an innate epithelial cell effector that mediates chronic allograft dysfunction. Am J Respir Crit Care Med 2006 174 : 461 70. (Pubitemid 44223128)
41. Frucht DM. IL-23: a cytokine that acts on memory T cells. Sci STKE 2002 114 : PE1.
42. Hunter CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol 2005 5 : 521 31. (Pubitemid 40961330)
43. Kryczek I, Wei S, Gong W et al. IFN-γ enables APC to promote memory Th17 and abate Th1 cell development. J Immunol 2008 181 : 5842 6.
44. Cella M, Scheidegger D, Palmer-Lehmann K, Lane P, Lanzavecchia A, Alber G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996 184 : 747 52. (Pubitemid 26324129)
45. Delgado JF, Sánchez V, de la Calzada CS et al. Impact of diltiazem administration and cyclosporine levels on the incidence of acute rejection in heart transplant patients. Transpl Int 2003 16 : 676 80. (Pubitemid 37193297)
46. Mies S, Massarollo PCB, Figueira ER, Leitäo RMC, Raia S. Lower incidence of liver graft rejection in patients on diltiazem plus cyclosporine therapy. Transpl Proc 1998 30 : 1437 8. (Pubitemid 28309634)
47. Chrysostomou A, Walker RG, Russ GR, d'Apice AJ, Kincaid-Smith P, Mathew TH. Diltiazem in renal allograft recipients receiving cyclosporine. Transplantation 1993 55 : 300 4. (Pubitemid 23065459)
48. Petrov V, Lijnen P. Inhibition of proliferation of human peripheral blood mononuclear cells by calcium antagonists. Role of interleukin-2. Methods Find Exp Clin Pharmacol 2000 22 : 19 23. (Pubitemid 30176411)
49. Yamanaka R, Yajima N, Abe T et al. Dendritic cell-based glioma immunotherapy Review Int J Oncol 2003 23 : 5 15. (Pubitemid 37288231)
50. Thomas-Kaskel AK, Waller CF, Schultze-Seemann W, Veelken H. Immunotherapy with dendritic cells for prostate cancer. Int J Cancer 2007 121 : 467 73. (Pubitemid 46986477)
51. Lesterhuis WJ, Aarntzen EH, De Vries IJ et al. Dendritic cell vaccines in melanoma: from promise to proof? Crit Rev Oncol Hematol 2008 66 : 118 34.